Washington, November 16
Pfizer Inc said on Tuesday it would allow generic manufacturers to supply its experimental antiviral Covid-19 pill to 95 low and middle-income countries through a licensing agreement with international public health group Medicines Patent Pool (MPP).
The voluntary licensing agreement between Pfizer and the MPP will allow the United Nations-backed group to grant sub-licences to qualified generic drug manufacturers to make their own versions of PF-07321332. — Reuters
(The article is generated from The Tribune via feeds, The Chenab Times staff didn’t wrote this news.)
❤️ Support Independent Journalism
Your contribution keeps our reporting free, fearless, and accessible to everyone.
Or make a one-time donation
Secure via Razorpay • 12 monthly payments • Cancel anytime before next cycle
(We don't allow anyone to copy content. For Copyright or Use of Content related questions, visit here.)
The Chenab Times News Desk